Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
6.28
-0.03 (-0.48%)
At close: Jul 24, 2025, 4:00 PM
6.33
+0.05 (0.80%)
After-hours: Jul 24, 2025, 7:24 PM EDT
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
$1,088,459
Profits / Employee
-$58,864
Market Cap
1.93B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FOLD News
- 3 days ago - Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025 - GlobeNewsWire
- 14 days ago - SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm - PRNewsWire
- 4 weeks ago - Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan - GlobeNewsWire
- 4 weeks ago - U.S. Supreme Court Decision Cites NCLA's Amicus Brief in Preserving Access to Federal Courts - GlobeNewsWire
- 5 weeks ago - The Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion Therapy - GlobeNewsWire
- 5 weeks ago - In NCLA Amicus Win, Supreme Court Revives Innocent Family's Suit over FBI's Wrong-House Raid - GlobeNewsWire
- 6 weeks ago - In NCLA Amicus Win, District Court Topples Kansas Dog Kennel No-Warrant Inspection Regime - GlobeNewsWire
- 6 weeks ago - Amicus Therapeutics: Opportunity Awaits In This Beaten Down Pharma - Seeking Alpha